Hiromichi Kimura
InvestorInvestor at Astellas Venture Management LLC
San Francisco Bay Area
Writes $100K – $5M checks · typically $1.5M
Find your path to Hiromichi
82 people in our graph share verified history with Hiromichi — schools, employers, funds. One of them is your warm intro.
About
Hiromichi Kimura, Ph.D., is a life sciences executive with clinical development and regulatory experience at companies including Shionogi, Takeda, Millennium, and Astellas Pharma, and has contributed to drug launches including ERIVEDGE, PADCEV, and VEOZAH. He currently serves as Founder and CEO of Bloom X³ and holds board director positions at multiple therapeutic companies spanning oncology, immunotherapy, and protein degradation platforms, while also advising venture capital funds across the US, Europe, and Asia. Kimura maintains an academic appointment at the University of Tokyo and previously led an early-stage drug discovery incubator at Kyoto University, bridging academic research with commercial development across Japan, the US, and Europe.
Experience
- Bloom X³Founder & CEOcurrent2025 — present
- The Global BloomingFounder & CEO2024 — 2025
- Astellas PharmaDirector/Lead2023 — 2024Tokyo, Japan
- Astellas Venture ManagementInvestment Director2018 — 2023San Francisco Bay Area
- Astellas PharmaResearch Manager/Senior Director2014 — 2018Japan
- Millennium Takeda Oncology CompanyDual position/Associate Director/Research head/Head of Department in Pharmacology2013 — 2014Cambridge, Massachusetts, United States
- TakedaAssociate Director/Research head/Head of Department in Pharmacology (SRC)2007 — 2014Japan
- St. Jude Children's Research Hospital - ALSACPostdoctoral Research Associate (Tom Curran, FRS lab)2001 — 2007Memphis, Tennessee, United States
- The University of TokyoPostdoctoral Research Fellow of JSPS for Young Scientist2000 — 2002
- Shionogi & Co., LtdClinical Development Associate1993 — 1994Osaka, Japan
Skills & more
+12 more
PharmaceuticalsCell BiologyPharmacovigilanceClinical DevelopmentOrganic ChemistryCell CultureRegulatory AffairsBiotechnologyCreative StrategyAnalysisINDLifesciencesLanguages English · Japanese
From Hiromichi's professional profile.
Colleagues at Astellas Venture Management LLC
Network1
Investors connected to Hiromichi in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Hiromichi Kimura?
- Hiromichi Kimura, Ph.D., is a life sciences executive with clinical development and regulatory experience at companies including Shionogi, Takeda, Millennium, and Astellas Pharma, and has contributed to drug launches including ERIVEDGE, PADCEV, and VEOZAH. He currently serves as Founder and CEO of Bloom X³ and holds board director positions at multiple therapeutic companies spanning oncology, immunotherapy, and protein degradation platforms, while also advising venture capital funds across the US, Europe, and Asia. Kimura maintains an academic appointment at the University of Tokyo and previously led an early-stage drug discovery incubator at Kyoto University, bridging academic research with commercial development across Japan, the US, and Europe.
- Where does Hiromichi Kimura work?
- Hiromichi Kimura is Investor at Astellas Venture Management LLC.
- What check size does Hiromichi Kimura write?
- Hiromichi Kimura typically writes checks of $100K – $5M.
- Where did Hiromichi Kimura go to school?
- Hiromichi Kimura studied at The University of Tokyo (PhD, Veterinary Medical Science, Molecular Celluar biology).
Same school
Also attended The University of Tokyo197
+ 191 more
Shared employers
Also worked at Bloom X³1
Also worked at Astellas Pharma17
+ 11 more
Also worked at Takeda52
+ 46 more
